Kazakhstan: Pfizer vaccine ready to be delivered

Kazakhstan is ready to deliver Pfizer vaccine against COVID-19 to its territory, First Vice Minister of Healthcare Marat Shoranov said on December 28. Shoranov revealed that the ministry had already signed the nondisclosure agreement with Pfizer and was ready to supply Kazakhstan with the vaccine. Everything, according to him, will depend on the ability of…

Kazakhstan: 100 mobile medical ventilators sent to Tajikistan

On December 22, Kazakhstan sent 100 mobile medical ventilators to Tajikistan by road, the Telegram Channel of the Kazakh Industry and Infrastructure Development Ministry reported. The ministry sent ventilators pursuant to the president’s task and instruction of the government of Kazakhstan dated December 10 “On rendering official humanitarian aid to Tajikistan”. The mobile ventilators are…



Ukraine: over 50% from COVID-19 Fund spent

As of October 23, UAH 34.1 billion, or 52%, has already been used from Ukraine’s COVID-19 Fund, the Finance Ministry’s press service reports. UAH 5.8 billion out of the planned UAH 16.3 billion or 35% was spent on healthcare. In particular, UAH 21 million was directed on the purchase of lung ventilation devices (UAH 100…

Kazakhstan: Atyrau region stockpiles pharmaceuticals for COVID-19 treatment sufficient for 3 months

The three-month stockpile of pharmaceuticals to treat the COVID-19 infection has been created in Atyrau region, Kazinform the press service of the press service of the region’s health office reports. 40 titles of the essential pharmaceuticals have been obtained through the social and business corporation Atyrau in order to ensure a stable supply of pharmaceuticals…

Kazakhstan: COVID-19 vaccine enters clinical trials

Clinical trials of Kazakhstani QazCovid-in vaccine against the COVID-19 virus developed by the Scientific Research Institute for Biological Safety Problems have started, the Ministry of Education and Science reports. Adult volunteers aged 18-50 years old will be involved in the clinical trials. Phase 1 trials will define the vaccine’s safety on 44 volunteers free of…